Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (2667)	3/23/2000 10:07:00 AM
From: Chris W.	Read Replies (3) \| Respond to of 2742

Sure Walter, I dug all this stuff out of public info back in Nov of 1998 when I sent a letter to all of CIST management including current and former Directors and also to the institutions encouraging them to take an active interest in the stock and its valuation and also to participate on this board. Predictably, no response, not even from that Hal: Management and Directors (you already have this I am sure): Bruce C. Galton, CEO of Cistron Richard S. Dondero, VP of Cistron Dr. Thomas P. Carney, Director Dr. Robert W. Naismith, Director Franklin J. Iris, Director Frank G. Stout, Director Henry Grausz, Former Director Isidore S. Edelman, Former Director Instutional owners: NEMC (302,289 shares) Mitch Creem Chief Financial Officer New England Medical Center 750 Washington Street Boston, MA 02111 Wellesley (136,870 shares) Catherine Feddersen Associate Treasurer Wellesley College Treasurer's Office 40 Grove Street, Suite 150 Wellesley, MA 02481